Current and historical daily PE Ratio for China National Medicines Corp Ltd (
) from 2002 to May 23 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. China National Medicines stock (SHSE:600511) PE ratio as of May 23 2024 is 12.01.
More Details
China National Medicines Corp Ltd (SHSE:600511) PE Ratio (TTM) Chart
China National Medicines Corp Ltd (SHSE:600511) PE Ratio (TTM) Historical Data
View and export this data going back to 2002. Start your Free Trial
Total 1195
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| China National Medicines PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-24 | 12.0 | 2024-03-20 | 10.4 |
| 2024-05-23 | 11.9 | 2024-03-19 | 10.5 |
| 2024-05-22 | 11.9 | 2024-03-18 | 10.7 |
| 2024-05-21 | 12.2 | 2024-03-15 | 10.7 |
| 2024-05-20 | 12.3 | 2024-03-14 | 10.7 |
| 2024-05-17 | 12.2 | 2024-03-13 | 10.8 |
| 2024-05-16 | 12.3 | 2024-03-12 | 10.8 |
| 2024-05-15 | 12.6 | 2024-03-11 | 10.7 |
| 2024-05-14 | 12.6 | 2024-03-08 | 10.7 |
| 2024-05-13 | 12.7 | 2024-03-07 | 10.6 |
| 2024-05-10 | 12.5 | 2024-03-06 | 10.8 |
| 2024-05-09 | 12.5 | 2024-03-05 | 10.9 |
| 2024-05-08 | 12.1 | 2024-03-04 | 11.2 |
| 2024-05-07 | 12.4 | 2024-03-01 | 11.1 |
| 2024-05-06 | 12.2 | 2024-02-29 | 11.1 |
| 2024-05-03 | 12.0 | 2024-02-28 | 10.9 |
| 2024-05-02 | 12.0 | 2024-02-27 | 11.1 |
| 2024-04-30 | 12.0 | 2024-02-26 | 11.0 |
| 2024-04-29 | 11.9 | 2024-02-23 | 11.2 |
| 2024-04-26 | 12.0 | 2024-02-22 | 11.2 |
| 2024-04-25 | 12.0 | 2024-02-21 | 11.0 |
| 2024-04-24 | 11.9 | 2024-02-20 | 11.2 |
| 2024-04-23 | 12.0 | 2024-02-19 | 11.0 |
| 2024-04-22 | 12.1 | 2024-02-16 | 11.1 |
| 2024-04-19 | 12.3 | 2024-02-09 | 11.1 |
| 2024-04-18 | 12.2 | 2024-02-08 | 11.1 |
| 2024-04-17 | 12.2 | 2024-02-07 | 11.2 |
| 2024-04-16 | 12.0 | 2024-02-06 | 10.7 |
| 2024-04-15 | 12.0 | 2024-02-05 | 10.2 |
| 2024-04-12 | 11.5 | 2024-02-02 | 9.9 |
| 2024-04-11 | 11.5 | 2024-02-01 | 10.1 |
| 2024-04-10 | 11.4 | 2024-01-31 | 10.5 |
| 2024-04-09 | 11.6 | 2024-01-30 | 10.6 |
| 2024-04-08 | 11.5 | 2024-01-29 | 10.9 |
| 2024-04-05 | 11.7 | 2024-01-26 | 10.8 |
| 2024-04-03 | 11.7 | 2024-01-25 | 10.9 |
| 2024-04-02 | 11.6 | 2024-01-24 | 9.9 |
| 2024-04-01 | 11.4 | 2024-01-23 | 9.8 |
| 2024-03-29 | 11.4 | 2024-01-22 | 9.8 |
| 2024-03-28 | 10.9 | 2024-01-19 | 10.3 |
| 2024-03-27 | 11.2 | 2024-01-18 | 10.5 |
| 2024-03-26 | 11.0 | 2024-01-17 | 10.2 |
| 2024-03-25 | 11.0 | 2024-01-16 | 10.4 |
| 2024-03-22 | 11.0 | 2024-01-15 | 10.5 |
| 2024-03-21 | 11.1 | 2024-01-12 | 10.3 |
China National Medicines Corp Ltd (SHSE:600511) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
China National Medicines Corp Ltd
NAICS : 325412
ISIN : CNE000001D56
Share Class Description:
SHSE:600511: Class ACompare
Compare
Traded in other countries / regions
600511.China IPO Date
2002-11-27Description
China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The Company has one main reportable segment, the Commercial segment, which consists of the operating segment of pharmaceutical sales. Its other reportable segments consist of pharmaceutical production and logistics segments The company is also engaged in proprietary Chinese medicines, Chinese medicine decoction pieces, Chinese medicinal materials, chemical preparations, chemical raw materials, antibiotics, and biochemical drugs.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers